Skip to main content

Cell Sensitivity Assays: The MTT Assay

  • Protocol
  • First Online:
Cancer Cell Culture

Part of the book series: Methods in Molecular Biology ((MIMB,volume 731))

Abstract

The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is based on the conversion of MTT into formazan crystals by living cells, which determines mitochondrial activity. Since for most cell populations the total mitochondrial activity is related to the number of viable cells, this assay is broadly used to measure the in vitro cytotoxic effects of drugs on cell lines or primary patient cells. In this chapter the protocol of the assay is described including important considerations relevant for each step of the assay as well as its limitations and possible applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaspers, G.J., Pieters, R., Van Zantwijk, CH., Van Wering, E.R., Van Der Does-Van Den Berg, A., Veerman, A.J. (1998) Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood. 92, 259–266.

    PubMed  CAS  Google Scholar 

  2. Salomons, G.S., Smets, L.A., Verwijs-Janssen, M., Hart, A.A., Haarman, E.G., Kaspers, G.J., Wering, E.V., Der Does-Van Den Berg, A.V., Kamps, W.A. (1999) Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia. 13, 1574–1580.

    Article  PubMed  CAS  Google Scholar 

  3. Kaspers G.J., Veerman A.J., Pieters R, Van Zantwijk CH., Smets L.A., Van Wering E.R., Van Der Does-Van Den Berg A. (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 90, 2723–2729.

    PubMed  CAS  Google Scholar 

  4. Kaspers, G.J., Wijnands, J.J., Hartmann, R., Huismans, L., Loonen, A.H., Stackelberg, A., Henze, G., Pieters, R., Hählen, K., Van Wering, E.R., Veerman, A.J. (2005) Immuno-phenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer. 41, 1300–1303.

    Article  PubMed  CAS  Google Scholar 

  5. Hubeek, I., Peters, G.J., Broekhuizen, R., Zwaan, C.M., Kaaijk, P., van Wering, E.S., Gibson, B.E., Creutzig, U., Janka-Schaub, G.E., den Boer, M.L., Pieters, R., Kaspers, G.J. (2006) In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. Haematologica. 91, 17–23.

    PubMed  CAS  Google Scholar 

  6. Oerlemans, R., Franke, N.E., Assaraf, Y.G., Cloos, J., van Zantwijk, I., Berkers, C.R., Scheffer, G.L., Debipersad, K., Vojtekova, K., Lemos, C., van der Heijden, J.W., Ylstra, B., Peters, G.J., Kaspers, G.J., Dijkmans, B.A., Scheper, R.J., Jansen, G. (2008) Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood. 112, 2489–2499.

    Article  PubMed  CAS  Google Scholar 

  7. Klumper E., Pieters R., Veerman A.J., Huismans D.R., Loonen A.H., Hählen K., Kaspers G.J., van Wering E.R., Hartmann R., Henze G. (1995) In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood. 86, 3861–3868.

    PubMed  CAS  Google Scholar 

  8. Kaspers G.J., Veerman A.J., Pieters R, Broekema G.J., Huismans D.R., Kazemier K.M., Loonen A.H., Rottier M.A., van Zantwijk CH., Hählen K. (1994) Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer. 70, 1047–1052.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by KiKa “Stichting Kinderen Kankervrij” – Dutch Children Cancer-free foundation and VONK “VUmc Onderzoek Naar Kinderkanker” foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacqueline Cloos .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

van Meerloo, J., Kaspers, G.J.L., Cloos, J. (2011). Cell Sensitivity Assays: The MTT Assay. In: Cree, I. (eds) Cancer Cell Culture. Methods in Molecular Biology, vol 731. Humana Press. https://doi.org/10.1007/978-1-61779-080-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-080-5_20

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-079-9

  • Online ISBN: 978-1-61779-080-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics